Grants and Contributions:

Back to search

Title:

Development of plant-based Nrf2 activator therapeutics to alleviate the severe complications of respiratory diseases

Agreement Number:

999609

Agreement Value:

$150,000.00

Agreement Date:

Jan 3, 2023 - Jul 3, 2023

Description:

National Research Council of Canada (NRC) is seeking potential therapeutics (ideally sub-micromolar potent) to treat respiratory disease by targeting viral infection, replication and/or address associated co-morbidities.

Organization:

National Research Council Canada

Expected Results:

Grow Canadian companies through direct funding to support early stage, pre-commercial research and development, late stage prototypes, and to accelerate commercialization.

Location:

Burnaby, British Columbia, CA V5M 3Z3

Reference Number:

172-2022-2023-Q3-999609

Agreement Type:

Grant

Report Type:

Grants and Contributions

Recipient Business Number:

821214632

Recipient Type:

For-profit organization

Recipient's Legal Name:

PharmaPlanter Technologies Inc

Research Organization:

National Research Council Canada/Conseil national de recherches Canada

Federal Riding Name:

Burnaby South

Federal Riding Number:

59003

Program:

Innovative Solutions Canada

Program Purpose:

Fuel the development and adoption of technological innovation in Canada

Coverage:

• Support the scale up and growth of Canada's innovators and entrepreneurs by having the federal government act as a first customer. • Stimuler l'expansion et la croissance des innovateurs et entrepreneurs canadiens en faisant du gouvernement fédéral le premier client des innovations canadiennes.

NAICS Code:

32541